Benitec Biopharma Inc.BNTCNASDAQ
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank33
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Latest
-20.55%
↑ 33% vs avg
Percentile
P33
Within normal range
Streak
1 yr
Consecutive declineDecelerating
Average
-30.48%
Historical baseline
PeriodValue
2025-20.55%
2024-8.71%
2023-13.20%
2022-21.90%
2021-71.07%
2020-273.94%
2019150.94%
2018-2.09%
201758.78%
2016-103.02%